IDEX Biometrics (IDEX) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
3 Mar, 2026Executive summary
Completed a strategic transformation to a product-focused company, launching certified biometric access cards and streamlining operations, with a focus on a single core product and expanded commercial leadership.
Achieved FIDO, Visa, Mastercard, and Microsoft certifications, enabling live customer deployments and supporting broader commercial rollout.
Secured initial paid customers and pilot agreements, with strong feedback from public and private sectors and system integrators.
Significant operational improvements included cost reductions, new hires in commercial roles, and a revamped website to drive inbound leads.
Did not achieve monthly sales exceeding OpEx by year-end; only 25% of this objective was met.
Financial highlights
Operating expenses reduced by 48–53% year-over-year, with Q4 2025 OpEx at $1.9 million and full-year OpEx at $9.7 million.
Q4 2025 revenue was $0.1 million, full-year 2025 revenue was $0.3 million, both down from prior year.
Net loss for 2025 was $10.0 million, improved from $14.4 million in 2024.
Cash balance at year-end was $0.7 million, with negative operating cash flow of $1.8 million in Q4 2025.
Gross margin remains negative due to low revenue and high fixed costs.
Outlook and guidance
FIDO certification unlocks enterprise and public sector opportunities, supporting expectations for revenue growth in 2026.
Pipeline is described as large and growing, with several large key account contracts in progress and international expansion planned.
Next-generation payment card (IDEX ONE) in development, targeting new business models for banks and issuers.
Cost reduction initiatives and recent capital raises underpin the going concern assumption for 2026.
Latest events from IDEX Biometrics
- Record backlog, improved margins, and accelerated commercial activity signal a strong 2026 outlook.IDEX
Q1 2026 - Q3 2025 saw a 60% OPEX drop, new biometric card launches, and ongoing liquidity risk.IDEX
Q3 2025 - Biometric access cards drive growth, aiming for breakeven in Q4 2025.IDEX
Company Presentation - Cost reductions and new funding support ongoing operations amid continued losses and product launches.IDEX
Q2 2025 - Q3 saw cost cuts, capital raised, and major biometric card approvals amid market risks.IDEX
Q3 2024 - Q2 revenue was $0.4M, margin 40%, costs down, but liquidity and growth risks remain.IDEX
Q2 2024 - Q1 2025 saw a $4.1M net loss, liquidity strain, and urgent need for new funding.IDEX
Q1 2025 - No Q4 revenue, net loss, and liquidity risk, but certifications and launches support future growth.IDEX
Q4 2024